SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is trending after the closing of its AI licensing partnership in Africa, establishing Skye Africa Intelligence. The community is actively discussing the strong potential for a short squeeze, citing the stock's low float, high cost-to-borrow, and increasing short interest.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending after reporting strong quarterly results and significantly raising its future revenue guidance, propelled by robust AI and data center demand. This has sparked widespread optimism among bulls, who anticipate further upside and analyst upgrades, although some in the community express caution regarding the sustainability of the rally.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending after its HLP004 Phase 2 results for Generalized Anxiety Disorder led to a significant stock sell-off, prompting community discussion over the data's efficacy nuances and ironic jokes about the company's ticker symbol, "$HELP." Investors are debating if the drop is an overreaction typical of biotech or justified by data concerns, with many viewing it as a buying opportunity.

Nutex Health, Inc. engages in the management and operation of healthcare facilities. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). The Population Health Division establishes and operates provider networks such as independent physician associations (IPAs). The Real State Division owns land and hospital buildings which are leased to hospital entities. The company was founded in 2011 and is headquartered in Houston, TX.

Nutex Health Inc

Nutex Health is trending following its Q4 earnings, which presented a revenue miss that management clarified with adjustments showing substantial annual growth and robust cash flow, alongside a new $25M share repurchase program. The community is actively debating these financial nuances and largely dismissing a new short report from Capybara Research as an unsubstantiated effort by short sellers to manipulate sentiment.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JD.com is trending due to a mixed reception to its latest earnings, which included an annual dividend and share buyback announcement, alongside reports of a swing to loss driven by investments in competitive sectors like food delivery. The community is actively debating whether the stock's deep value and strong cash position will overcome persistent underperformance, exacerbated by broader concerns about China's economic outlook and intense market competition.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending after a mixed earnings report that included a revenue beat, an EPS miss, and the announcement of CEO Doug Ingram's retirement, prompting community discussions about potential M&A and future leadership. Investors are also keenly anticipating upcoming Q1 data readouts for key pipeline assets like DM1 and FSHD, alongside ongoing debate over the impact of a potentially more streamlined regulatory environment for rare disease gene therapies on the company's valuation.

South Bow Corp.is an energy infrastructure company. It engages in the construction and operation of pipelines that transport crude oil and other liquids across Canada and the United States. The company was founded on December 15, 2023 and is headquartered in Calgary, Canada.

South Bow Corp.

South Bow Corp. (SOBO) is trending after reporting strong Q4 earnings and a positive 2026 EBITDA forecast, with community discussion centered on the potential revival of the Keystone Pipeline XL and the stock's attractive dividend yield.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF is witnessing a rapid rebound, with its core holdings Samsung and SK Hynix leading a significant surge in the KOSPI index. Community discussion highlights that strong fundamentals in the AI-driven memory chip supercycle are overshadowing recent geopolitical concerns, positioning South Korean tech as an attractive and undervalued opportunity.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne (TER) initially rallied significantly on a strong Q4 earnings beat and optimistic guidance, propelled by surging AI-driven demand in its semiconductor test and robotics divisions. However, the market is now reacting to cautious commentary during the post-earnings conference call, leading to a notable pullback despite the strong underlying AI tailwinds that continue to fuel community discussion.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending after announcing a major acquisition that promises to significantly expand its subsea technology capabilities and revenue. While the deal involves some share dilution, the community is largely bullish, viewing it as a transformative step solidifying Kraken's position in the growing defense and autonomous underwater vehicle sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Nutex Health, Inc. Bottom Line Advances In Full Year

(RTTNews) - Nutex Health, Inc. (NUTX) announced a profit for its full year that Increased, from the same period last year...

NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM

NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM PR Newswire...

Nutex Health Earnings Report: Q4 Overview

Nutex Health (NUTX) Expected to Announce Quarterly Earnings on Thursday

Nutex Health (NASDAQ:NUTX) will be releasing its Q4 2025 earnings after the market closes on Thursday, March 5. (View Earnings Report at...

Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings...

Nutex Health (NASDAQ:NUTX) Shares Up 7.4% - Time to Buy?

Nutex Health (NASDAQ:NUTX) Trading 7.4% Higher - Here's What Happened...

Nutex Health (NASDAQ:NUTX) Stock Price Up 7.8% - Here's Why

Nutex Health (NASDAQ:NUTX) Trading 7.8% Higher - Should You Buy...

Nutex Health (NASDAQ:NUTX) Trading 8.3% Higher - Should You Buy?

Nutex Health (NASDAQ:NUTX) Stock Price Up 8.3% - Time to Buy...

SummerHaven Investment Management LLC Invests $748,000 in Nutex Health Inc. $NUTX

SummerHaven Investment Management LLC bought a new stake in Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with...

Nutex Health (NASDAQ:NUTX) Trading 12.5% Higher - Still a Buy?

Nutex Health (NASDAQ:NUTX) Shares Up 12.5% - What's Next...

$NUTX Q4 &#39;25 Earnings Results &amp; Recap

• Reported GAAP EPS of $1.50 down -87.32% YoY
• Reported revenue of $151.68M down -41.12% YoY

Stocktwits

 Q4 '25 Earnings Results & Recap

• Reported GAAP EPS of $1.50 down -87.32% YoY
• Reported revenue of $151.68M down -41.12% YoY

NUTX
Nutex Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest NUTX News

NUTXNutex Health Inc